Last reviewed · How we verify
mometasone nasal inhalation
Mometasone is a corticosteroid that works by inhibiting the release of pro-inflammatory cytokines and mediators.
Mometasone is a corticosteroid that works by inhibiting the release of pro-inflammatory cytokines and mediators. Used for Allergic rhinitis, Chronic rhinitis.
At a glance
| Generic name | mometasone nasal inhalation |
|---|---|
| Also known as | Nasonex® |
| Sponsor | Sumitomo Pharma America, Inc. |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 3 |
Mechanism of action
This leads to a reduction in inflammation and swelling in the nasal passages, providing relief from symptoms of allergic rhinitis. Mometasone's mechanism of action is similar to other corticosteroids, but its potency and duration of action are unique.
Approved indications
- Allergic rhinitis
- Chronic rhinitis
Common side effects
- Nasal irritation
- Headache
- Nasal congestion
- Nasal dryness
- Throat irritation
Key clinical trials
- Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children (PHASE4)
- Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion (NA)
- Allergic Rhinitis With/Without Asthma: Pre- and Post-Qipian Analysis
- The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726) (PHASE4)
- Multi-disciplinary Diagnosis and Treatment Process and Evaluation System for Children With Sleep Disordered Breathing and Malocclusion (NA)
- Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays (PHASE4)
- Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) (PHASE3)
- Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- mometasone nasal inhalation CI brief — competitive landscape report
- mometasone nasal inhalation updates RSS · CI watch RSS
- Sumitomo Pharma America, Inc. portfolio CI